메뉴 건너뛰기




Volumn 28, Issue 6, 2005, Pages 363-366

Final height in short polytransfused thalassemia major patients treated with recombinant growth hormone

Author keywords

Final height; Recombinant GH therapy; Thalassemia major

Indexed keywords

RECOMBINANT GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT PROTEIN;

EID: 23444435277     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03347204     Document Type: Article
Times cited : (16)

References (23)
  • 1
    • 0002071898 scopus 로고
    • Growth in homozygous β-thalassemia patients
    • Cavallo L, Job JC, New MI eds. Serono Symposia No. 81. Rome: Raven Press
    • Cavallo L, De Mattia D, Giobbe T, et al. Growth in homozygous β-thalassemia patients. In: Cavallo L, Job JC, New MI eds. Growth Disorders: the State of the art. Serono Symposia No. 81. Rome: Raven Press 1991, 47-54.
    • (1991) Growth Disorders: The State of the Art , pp. 47-54
    • Cavallo, L.1    De Mattia, D.2    Giobbe, T.3
  • 2
    • 0027768637 scopus 로고
    • Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study
    • Garcia-Mayor RVG, Andrade Olivie A, Fernandez Catalina P, et al. Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study. Horm Res 1993, 40: 189-93.
    • (1993) Horm Res , vol.40 , pp. 189-193
    • Garcia-Mayor, R.V.G.1    Andrade Olivie, A.2    Fernandez Catalina, P.3
  • 4
    • 0017261757 scopus 로고
    • Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty
    • Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976, 51: 170-9.
    • (1976) Arch Dis Child , vol.51 , pp. 170-179
    • Tanner, J.M.1    Whitehouse, R.H.2
  • 8
    • 0031778827 scopus 로고    scopus 로고
    • Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with β-thalassemia major and the effect of GH treatment
    • Low LCK, Postel-Vinay MC, Kwan EYW, Cheung PT. Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with β-thalassemia major and the effect of GH treatment. Clin Endocrinol (Oxf) 1998, 48: 641-6.
    • (1998) Clin Endocrinol (Oxf) , vol.48 , pp. 641-646
    • Low, L.C.K.1    Postel-Vinay, M.C.2    Kwan, E.Y.W.3    Cheung, P.T.4
  • 10
    • 0025950673 scopus 로고
    • Treatment with biosinthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion
    • Scacchi M, Danesi L, De Martin M, et al. Treatment with biosinthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion. Clin Endocrinol (Oxf) 1991, 35: 335-9.
    • (1991) Clin Endocrinol (Oxf) , vol.35 , pp. 335-339
    • Scacchi, M.1    Danesi, L.2    De Martin, M.3
  • 11
    • 0028940585 scopus 로고
    • Growth hormone treatment of short Chinese children with β-thalassemia major without GH deficiency
    • Low LCK, Kwan EYM, Lim YJ, Lee ACW, Tam CF, Lam KSL. Growth hormone treatment of short Chinese children with β-thalassemia major without GH deficiency. Clin Endocrinol (Oxf) 1995, 42: 359-63.
    • (1995) Clin Endocrinol (Oxf) , vol.42 , pp. 359-363
    • Low, L.C.K.1    Kwan, E.Y.M.2    Lim, Y.J.3    Lee, A.C.W.4    Tam, C.F.5    Lam, K.S.L.6
  • 12
    • 0031110401 scopus 로고    scopus 로고
    • L'accrescimento staturale nella talassemia
    • De Sanctis V, Urso L. L'accrescimento staturale nella talassemia. Minerva Pediatr 1997, 49: 121-8.
    • (1997) Minerva Pediatr , vol.49 , pp. 121-128
    • De Sanctis, V.1    Urso, L.2
  • 13
    • 0031980550 scopus 로고    scopus 로고
    • GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with β-thalassemia
    • Soliman AT, El Banna N, Ansari BM. GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with β-thalassemia. Eur J Endocrinol 1998, 138: 394-400.
    • (1998) Eur J Endocrinol , vol.138 , pp. 394-400
    • Soliman, A.T.1    El Banna, N.2    Ansari, B.M.3
  • 14
    • 0033451916 scopus 로고    scopus 로고
    • Recombinant human growth hormone treatment in children with thalassemia major
    • Arcasoy A, Ocal G, Kemahli S, et al. Recombinant human growth hormone treatment in children with thalassemia major. Pediatr Int 1999, 41: 655-61.
    • (1999) Pediatr Int , vol.41 , pp. 655-661
    • Arcasoy, A.1    Ocal, G.2    Kemahli, S.3
  • 15
    • 0032424337 scopus 로고    scopus 로고
    • Short-term therapy with recombinant growth hormone in polytransfused thalassemia major patients with growth deficiency
    • Cavallo L, Gurrado R, Zecchino C, et al. Short-term therapy with recombinant growth hormone in polytransfused thalassemia major patients with growth deficiency. J Pediatr Endocrinol Metab 1998, 11: 845-9.
    • (1998) J Pediatr Endocrinol Metab , vol.11 , pp. 845-849
    • Cavallo, L.1    Gurrado, R.2    Zecchino, C.3
  • 17
    • 0036420133 scopus 로고    scopus 로고
    • Growth and puberty and its management in thalassemia
    • De Sanctis V. Growth and puberty and its management in thalassemia. Horm Res 2002, 58 (Suppl 1): 72-9.
    • (2002) Horm Res , vol.58 , Issue.SUPPL. 1 , pp. 72-79
    • De Sanctis, V.1
  • 18
    • 0031006274 scopus 로고    scopus 로고
    • Growth, puberty and endocrine function in beta-thalassemia major
    • Low LCK. Growth, puberty and endocrine function in beta-thalassemia major. J Pediatr Endocrinol Metab 1997, 10: 175-84.
    • (1997) J Pediatr Endocrinol Metab , vol.10 , pp. 175-184
    • Low, L.C.K.1
  • 19
    • 0034060104 scopus 로고    scopus 로고
    • The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with β-thalassemia major
    • Kwan EYW, Tam SCF, Cheung PT, Low LCK. The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with β-thalassemia major. J Pediatr Endocrinol Metab 2000, 13: 545-52.
    • (2000) J Pediatr Endocrinol Metab , vol.13 , pp. 545-552
    • Kwan, E.Y.W.1    Tam, S.C.F.2    Cheung, P.T.3    Low, L.C.K.4
  • 20
    • 0034794175 scopus 로고    scopus 로고
    • Recombinant growth hormone treatment in short thalassemia major patients: Results after 24 and 36 months
    • Cavallo L, Acquafredda A, Zecchino C, et al. Recombinant growth hormone treatment in short thalassemia major patients: results after 24 and 36 months. J Pediatr Endocrinol Metab 2001, 14: 1133-7.
    • (2001) J Pediatr Endocrinol Metab , vol.14 , pp. 1133-1137
    • Cavallo, L.1    Acquafredda, A.2    Zecchino, C.3
  • 21
    • 0242439285 scopus 로고    scopus 로고
    • Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment
    • Wu KH, Tsai FJ, Peng CT. Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol 2003, 82: 637-40.
    • (2003) Ann Hematol , vol.82 , pp. 637-640
    • Wu, K.H.1    Tsai, F.J.2    Peng, C.T.3
  • 22
    • 0142025217 scopus 로고    scopus 로고
    • Growth hormone secretion in polytransfused prepubertal patients with homozygous beta-thalassemia. Effect of long-term recombinant GH (recGH) therapy
    • Masala A, Atzeni MM, Alagna S, et al. Growth hormone secretion in polytransfused prepubertal patients with homozygous beta-thalassemia. Effect of long-term recombinant GH (recGH) therapy. J Endocrinol Invest 2003, 26: 623-8.
    • (2003) J Endocrinol Invest , vol.26 , pp. 623-628
    • Masala, A.1    Atzeni, M.M.2    Alagna, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.